Beth Rosenshein
Beth is an electrical/bio-medical engineer. She has two United States patents, one for a unique design of a vaginal speculum, and one for a clever urinary collection device specifically designed for women and a patent pending for an intravaginal data collection device. Beth discovered and documented an important drug interaction between esomeprazole (Nexium™) and testosterone. Her findings were published in a case study in The American Journal of the Medical Sciences in May 2004. She petitioned the FDA in August 2003 to change the labeling on hormone products. The petition was granted in September 2004 changing the labeling on all estrogen products. She also wrote a book, on how to extend the functional life of the ovaries which could postpone menopause by decades, Preventing Menopause, How to Stop Menopause Before it Starts. Beth is also a wife and mother and lives in Boulder, CO.

Leon Rosenshein
Leon is a mechanical/aerospace engineer with an MBA currently working in the software industry. He has served on the board of several non-profit organizations.

Together, Leon and Beth founded Diamond Research Foundation.

Susan Marcolina, MD, FACP
Medical Director

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.